Grants and Contributions:
Title:
ARP - Development of rabbit antibodies for the detection of human cancer
Agreement Number:
905044
Agreement Value:
$50,000.00
Agreement Date:
Apr 1, 2018 - Mar 14, 2019
Description:
ARP - Development of rabbit antibodies for the detection of human cancer
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H3J 1S6
Reference Number:
172-2018-2019-Q1-905044
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
747665529
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 111 days.
Amendment Date
Nov 20, 2018
Recipient's Legal Name:
Pharma Glycovax Inc
Federal Riding Name:
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding Number:
24077
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: